Uta Schwanebeck

2.1k total citations · 1 hit paper
34 papers, 1.6k citations indexed

About

Uta Schwanebeck is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Uta Schwanebeck has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Uta Schwanebeck's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Uta Schwanebeck is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Uta Schwanebeck collaborates with scholars based in Germany, United States and Switzerland. Uta Schwanebeck's co-authors include M Hanefeld, Ulrich Julius, H Schmechel, Jan Schulze, Joachim Lindner, Sven Fischer, H J Ziegelasch, Sabine Fischer, Christina Köhler and Steven M. Haffner and has published in prestigious journals such as PLoS ONE, Neurology and Diabetes Care.

In The Last Decade

Uta Schwanebeck

33 papers receiving 1.5k citations

Hit Papers

Risk factors for myocardial infarction and death in newly... 1996 2026 2006 2016 1996 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
    1996 708 citations M Hanefeld, Sven Fischer et al. Diabetologia profile →

Peers

Uta Schwanebeck
Neslihan Başçıl Tütüncü Türkiye
Di̇lek Gogas Yavuz Türkiye
Martin Pfohl Germany
Shuhei Nakanishi Japan
Donald A. Bergman United States
Sung Kil Lim South Korea
Jung‐Fu Chen Taiwan
Tore Julsrud Berg Norway
James M. Falko United States
Carlos Morillas Spain
Neslihan Başçıl Tütüncü Türkiye
Uta Schwanebeck
Citations per year, relative to Uta Schwanebeck Uta Schwanebeck (= 1×) peers Neslihan Başçıl Tütüncü

Countries citing papers authored by Uta Schwanebeck

Since Specialization
Citations

This map shows the geographic impact of Uta Schwanebeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Schwanebeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Schwanebeck more than expected).

Fields of papers citing papers by Uta Schwanebeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uta Schwanebeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Schwanebeck. The network helps show where Uta Schwanebeck may publish in the future.

Co-authorship network of co-authors of Uta Schwanebeck

This figure shows the co-authorship network connecting the top 25 collaborators of Uta Schwanebeck. A scholar is included among the top collaborators of Uta Schwanebeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uta Schwanebeck. Uta Schwanebeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seebauer, Christian, Heike Rudolph, Uta Schwanebeck, et al.. (2020). Results of a randomised controlled trial between an ORC collagen hemostatic agent and a carrier-bound fibrin sealant. Journal of Visceral Surgery. 158(1). 11–18. 2 indexed citations
2.
Rahbari, Nuh N., Emrullah Birgin, Dorothée Sturm, et al.. (2019). Randomized clinical trial of BioFoam® Surgical Matrix to achieve hemostasis after liver resection. HPB. 22(7). 987–995. 12 indexed citations
3.
4.
Ehehalt, Florian, Dorothée Sturm, Manuela B. Rösler, et al.. (2015). Blood Glucose Homeostasis in the Course of Partial Pancreatectomy – Evidence for Surgically Reversible Diabetes Induced by Cholestasis. PLoS ONE. 10(8). e0134140–e0134140. 17 indexed citations
5.
6.
7.
Storch, Alexander, Martin Wolz, Bettina Beuthien‐Baumann, et al.. (2013). Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease. Neurology. 80(19). 1754–1761. 18 indexed citations
8.
Schwanebeck, Uta, et al.. (2013). Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease. Therapeutic Advances in Endocrinology and Metabolism. 4(3). 83–94. 37 indexed citations
9.
Wolz, Martin, Christine Schneider, Florian Proft, et al.. (2012). Comparison of chocolate to cacao-free white chocolate in Parkinson’s disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial. Journal of Neurology. 259(11). 2447–2451. 13 indexed citations
10.
Schindler, Christoph, et al.. (2011). Characterization of Local Vascular Effects of the Nitric Oxide Inhibitor NG‐Monomethyl‐L‐Arginine on Dorsal Hand Veins. The Journal of Clinical Pharmacology. 52(6). 859–869. 3 indexed citations
11.
Wolz, Martin, Matthias Löhle, Karl Strecker, et al.. (2010). Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Journal of Neural Transmission. 117(11). 1279–1286. 37 indexed citations
12.
Schellong, Sebastian, Sylvia Haas, Andreas Greinacher, et al.. (2010). An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN. Expert Opinion on Pharmacotherapy. 11(18). 2953–2961. 22 indexed citations
13.
Aschoff, Roland, Uta Schwanebeck, Matthias Bräutigam, & Michael J. Meurer. (2008). Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild‐to‐moderate atopic dermatitis. Experimental Dermatology. 18(1). 24–29. 27 indexed citations
14.
Schmitt, Jochen, Michael J. Meurer, Uta Schwanebeck, Xina Grählert, & Knut Schäkel. (2008). Treatment Following an Evidence-Based Algorithm versus Individualised Symptom-Oriented Treatment for Atopic Eczema. Dermatology. 217(4). 299–308. 9 indexed citations
15.
Plaschke, Jens, Uta Schwanebeck, Steffen Pistorius, H. D. Saeger, & Hans K. Schackert. (2003). Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Letters. 191(2). 179–185. 43 indexed citations
16.
Fischer, Sabine, Andreas Patzak, Hannes Rietzsch, et al.. (2003). Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients. Diabetes Obesity and Metabolism. 5(1). 38–44. 31 indexed citations
17.
Fischer, Sabine, M Hanefeld, Steven M. Haffner, et al.. (2002). Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetologica. 39(3). 105–110. 124 indexed citations
18.
19.
Hanefeld, M, H Schmechel, Uta Schwanebeck, & Joachim Lindner. (1997). Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience. Diabetologia. 40(0). S123–S124. 34 indexed citations
20.
Hanefeld, M, Sven Fischer, Ulrich Julius, et al.. (1996). Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 39(12). 1577–1583. 708 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neslihan Başçıl Tütüncü Breakdown of academic impact, for papers by Di̇lek Gogas Yavuz Breakdown of academic impact, for papers by Martin Pfohl Breakdown of academic impact, for papers by Shuhei Nakanishi Breakdown of academic impact, for papers by Donald A. Bergman Breakdown of academic impact, for papers by Sung Kil Lim Breakdown of academic impact, for papers by Jung‐Fu Chen Breakdown of academic impact, for papers by Tore Julsrud Berg Breakdown of academic impact, for papers by James M. Falko Breakdown of academic impact, for papers by Carlos Morillas
Rankless by CCL
2026